Traffic Roots Audience Pixel
RAPID,
AFFORDABLE
COVID-19
CLADE VARIANT
DETECTION.
DETECTION MADE ACCESSIBLE.
Rapid, affordable Variant Detection for SARS-CoV-2 is now available thanks to the PathogenDx Microarray. Our NIH-supported technology provides invaluable insight to guide scientific discovery and public health decision- making—today not someday. And without the time and expense of sequencing.
DetectX-CV_Logo_375
  • All major variants detected
  • Variant results in 4 hours after positive sample from a Q-PCR test
  • Run up to 576 samples in a single shift
  • A fraction of the cost of NGS Sequencing
NEW: SARS-CoV-2 VARIANT WEBINAR
View a Live Presentation by PathogenDx Scientists on the DetectX-Cv Variant test, and Customer User Feedback by TriCore Reference labs, one of the leading clinical diagnostics labs in the US.
Variant/Mutation Identification is designed for Research Use Only (RUO)
SARS-CoV-2 virus clade variant testing
The Technology at a glance: DetectX-Cv is a Multiplexed MicroArray technology that identifies SARS-CoV-2 variants in RNA isolated from samples utilizing our patented Asymmetric One-Step RT-PCR coupled with a DNA MicroArray Hybridization. The SARS-CoV-2 viral mutation targets are simultaneously identified and include: COVID-19 (Wuhan N1, N2) and Clades (EU, UK, Brazil, Japan, India, US).
COMPARING COVID-19 VARIANT
DETECTION TECHNOLOGIES.
Technology
DetectX-CV_Logo_375
Mass Array Panel
NGS Sequencing
Time To Results
4 hr
8 hr
96 hr
Test Cost
$25
$25
$150-$400
Equipment Cost
<$60K
$250K+
$850K-$1M
Technology
Time To Results
Time To Cost
Equipment Cost
DetectX-CV_Logo_375
4 hr
$25
<$60K
Mass Array Panel
8 hr
$25
$250K+
NGS Sequencing
96 hr
$150-$400
$850K-$1M
Applications:
  • Vaccine Efficacy Monitoring
  • Pharmaceutical Research
  • Public Health Response Planning
  • Educational Research
  • Product Development
Supported by
NIH Logo
PathogenDx testing is supported by The National Institutes of Health (NIH) as part of the Rapid Acceleration of Diagnostics (RADx) program. DetectX-Cv joins DetectX-Rv as part of our rapid response in innovation to address COVID-19.
PathogenDx_Logo
INQUIRE ABOUT PATHOGENDx
CLADE VARIANT DETECTION
Pooled surveillance of Covid-19

    96 well microarray for testing of bacteria, virus, mold, and other pathogens
    Read our Variant Detection
    Press Release.
    Discover more about
    PathogenDx and its solutions.
    Variant/Mutation Identification is designed for Research Use Only (RUO)